Phase II study of afatinib, an irreversible ErbB family blocker, in demographically and genotypically defined lung adenocarcinoma
2015 · Lung Cancer · 88 citations
https://doi.org/10.1016/j.lungcan.2015.01.013
M
Marie-Pascale Graas
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
41
Papers
664
Citations
9
h-index
7
i10-index
Marie-Pascale Graas is an academic researcher from Clinique Saint-Joseph. The author has contributed to research in topics: Estrogen and related hormone effects & Advanced Breast Cancer Therapies & Breast Cancer Treatment Studies. The author has an h-index of 9, co-authored 35 publications.
Papers by this author
worksThe efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer
2021 · Breast Cancer Research and Treatment · 30 citations
https://doi.org/10.1007/s10549-021-06109-7
Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy
2021 · Annals of Oncology · 30 citations
https://doi.org/10.1016/j.annonc.2021.07.017
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat